Quality of life considerations in the treatment of metastatic hormone-sensitive prostate cancer

Chambers, SK

Frydenberg, M Dunn, J

Permalink

Closed Access

	Filename	Description	Size
	Quality of life considerations in the treatment of metastatic hormone-sensitive prostate cancer..pdf	Published Version	277.38 kB	Adobe PDF	View/Open

Copyright Clearance Process

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Chambers, SK https://orcid.org/0000-0003-2369-6111	en_US
dc.contributor.author	Frydenberg, M	en_US
dc.contributor.author	Dunn, J	en_US
dc.date.available	2019-09-16	en_US
dc.date.issued	2019-11-01	en_US
dc.identifier.citation	The Lancet Oncology, 2019, 20 (11), pp. 1469 - 1471	en_US
dc.identifier.issn	1470-2045	en_US
dc.identifier.uri	http://hdl.handle.net/10453/139208
dc.relation.ispartof	The Lancet Oncology	en_US
dc.relation.isbasedon	10.1016/S1470-2045(19)30628-X	en_US
dc.subject.classification	Oncology & Carcinogenesis	en_US
dc.title	Quality of life considerations in the treatment of metastatic hormone-sensitive prostate cancer	en_US
dc.type	Journal Article
utslib.citation.volume	11	en_US
utslib.citation.volume	20	en_US
utslib.for	1112 Oncology and Carcinogenesis	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
utslib.copyright.status	closed_access
pubs.issue	11	en_US
pubs.publication-status	Published	en_US
pubs.volume	20	en_US

Please use this identifier to cite or link to this item: